FDA: Generics Approved in 2017 Led to $8.8B in Savings

In a first of its kind report, the US Food and Drug Administration (FDA) says that generic drugs approved in 2017 led to $8.8 billion in cost savings during the calendar year, and $11.8 billion in savings through February 2018.